Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & PepGen

2 shared events · Importance 3 · Last updated Jul 20, 2025

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
0
Regulatory
PepGen: PepGen is being sued for allegedly issuing materially false and/or misleading statements regarding its lead product candidate, PGN-EDO51, and its CONNECT2 study, which could lead to financial losses for the company and its shareholders.
Jun 12, 2025 · 6 articles
0
Business
PepGen: PepGen is facing a class action lawsuit due to alleged false statements regarding the effectiveness and safety of its lead product candidate, PGN-EDO51, and the CONNECT2 study.
Jun 11, 2025 · 17 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and PepGen interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.